StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
BMO Capital Reiterates Outperform on Bristol-Myers Squibb (BMY)
January 25, 2019 8:45 AM
BMO Capital analyst, Alex Arfaei, reiterated an Outperform rating and $60.00 price target on Bristol-Myers Squibb Co. (NYSE: BMY) following ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Next Articles
Bristol-Myers Squibb Co. (BMY) PT Raised to $53 at BofA/Merrill Lynch
January 25, 2019 6:07 AM
Active options: BAC SQ SBUX F QCOM BMY FCX BABA PCG AMZN MSFT
January 25, 2019 5:03 AM
Canaccord Genuity Sees Bristol-Myers Acquiring Control of bb2121 from bluebird bio (BLUE)
January 24, 2019 10:32 AM
Bristol-Myers Squibb (BMY) Tops Q4 EPS by 9c, Offers FY19 Guidance
January 24, 2019 7:00 AM
Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results
January 24, 2019 6:59 AM
Bristol-Myers Squibb Announces Time Change for Q4 Earnings Results Conference Call
January 24, 2019 6:59 AM
Popular stocks with increasing volume: BMY PG CSCO INTC QCOM
January 24, 2019 4:55 AM
Popular stocks with increasing volume: SBUX BMY FCAU F ARNC BBT IBM
January 23, 2019 5:25 AM
